{"schema_version":"secwatch.filing_event.v1","accession":"0001753926-24-000545","form_type":"8-K","ticker":"LIPO","cik":"0001347242","company_name":"LIPELLA PHARMACEUTICALS INC.","filed_at":"2024-03-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.886829+00:00","generated_at":"2026-06-04T16:53:46.636593+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"CEO and CMO each purchase $100k of Lipella common stock at $0.6901/share","bullets":["CEO Jonathan Kaufman bought 144,906 shares for $100,000 at $0.6901/share on March 12, 2024.","CMO Michael Chancellor bought 144,906 shares for $100,000 at same price and date.","Total insider investment of $200,000; shares subject to six-month restricted period.","Proceeds provide working capital; shares issued directly from company treasury."],"urls":{"canonical":"https://secwatch.observer/filing/0001753926-24-000545","json":"https://secwatch.observer/filing/0001753926-24-000545.json","markdown":"https://secwatch.observer/filing/0001753926-24-000545.md","text":"https://secwatch.observer/filing/0001753926-24-000545.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1347242/000175392624000545/0001753926-24-000545-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1347242/000175392624000545/g084127_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T16:53:46.636593+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}